BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25532855)

  • 1. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
    Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
    Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
    Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
    Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA expression profiles in oral squamous cell carcinoma.
    Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
    Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
    Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
    Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of altered miRNA expression in whole blood of OSCC patients.
    Ries J; Baran C; Wehrhan F; Weber M; Neukam FW; Krautheim-Zenk A; Nkenke E
    Oncol Rep; 2017 Jun; 37(6):3467-3474. PubMed ID: 28498442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.
    Ghosh RD; Ghuwalewala S; Das P; Mandloi S; Alam SK; Chakraborty J; Sarkar S; Chakrabarti S; Panda CK; Roychoudhury S
    Sci Rep; 2016 Apr; 6():23932. PubMed ID: 27045798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
    Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
    Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
    Ghantous Y; Bahouth Z; Abu El-Naaj I
    Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
    Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.
    Reis PP; Waldron L; Perez-Ordonez B; Pintilie M; Galloni NN; Xuan Y; Cervigne NK; Warner GC; Makitie AA; Simpson C; Goldstein D; Brown D; Gilbert R; Gullane P; Irish J; Jurisica I; Kamel-Reid S
    BMC Cancer; 2011 Oct; 11():437. PubMed ID: 21989116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
    Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
    PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
    Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
    Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.
    Moratin J; Hartmann S; Brands RC; Horn D; Fuchs A; Mutzbauer G; Seher A; Scholz C; Müller-Richter UDA; Linz C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):523-529. PubMed ID: 30709758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
    Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
    Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of lncRNA CASC2 promotes the postoperative local recurrence of early oral squamous cell carcinoma.
    Dong Y; Wu W
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):605-610. PubMed ID: 30467776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.